A central review of resectability of optimally unresectable colorectal liver metastases following neoadjuvant chemotherapy (KSCC0802).
Mitsuhisa Takatsuki
No relevant relationships to disclose
Susumu Eguchi
No relevant relationships to disclose
Shoji Tokunaga
No relevant relationships to disclose
Yasunori Emi
No relevant relationships to disclose
Eiji Oki
No relevant relationships to disclose
Shinji Uchida
No relevant relationships to disclose
Masahiko Sakoda
No relevant relationships to disclose
Yoshihiro Kakeji
No relevant relationships to disclose
Ken Shirabe
No relevant relationships to disclose
Yoshito Akagi
No relevant relationships to disclose
Toru Beppu
No relevant relationships to disclose
Hideo Baba
No relevant relationships to disclose
Shinichi Ueno
No relevant relationships to disclose
Shoji Natsugoe
No relevant relationships to disclose
Yutaka Ogata
No relevant relationships to disclose
Yoshihiko Maehara
Research Funding - Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha